Analyst Profile

Followed by 1,145 followers
.
Vernon Bernardino

Vernon Bernardino

H.C. Wainwright
Wall Street Analyst
#460 out of 8,141 Wall Street Analysts
#888 out of 24,284 experts

Success Rate

31%
135 out of 433 transactions made a profit

Average Return

+17.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Vernon Bernardino's trades since 2013 and holding each position for 1 Year would result in 31.18% of your transactions generating a profit, with an average return of 17.6% per rating.

Stock Rating Distribution

749Ratings
95.86% Buy
4.14% Hold
0.00% Sell
Distribution of Vernon Bernardino's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Novavax
(NVAX)
Rating:Buy
Date:Apr 30, 2020 - Apr 30, 2021
Return:+800.00%
The most profitable rating made by Vernon Bernardino

Vernon Bernardino's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Alaunos Therapeutics
Mar 27, 2013
Hold
Downgraded
$1.50
(130.84% Upside)
1Ratings
0.00%
Fresh Tracks Therapeutics
Jun 17, 2013
Buy
Initiated
$70.00
(3435.35% Upside)
1Ratings
0.00%
Vericel
Nov 13, 2013
Hold
Reiterated
$4.50
(-79.80% Downside)
1Ratings
0.00%
ImmunoCellular Therapeutics
Dec 12, 2013
Hold
Downgraded
$1.30
(41.30% Upside)
2Ratings
0.00%
Dynavax
Mar 02, 2015
Buy
Reiterated
$25.00
(105.09% Upside)
4Ratings
0.00%
Pacira Pharmaceuticals
Mar 25, 2015
Buy
Reiterated
$15.00
(-68.29% Downside)
1Ratings
0.00%
Lisata Therapeutics
Apr 20, 2015
Buy
Reiterated
$14.00
(288.89% Upside)
4Ratings
0.00%
BioCryst
Aug 10, 2015
Buy
Reiterated
$15.00
(13.51% Upside)
4Ratings
0.00%
NRXGQ
NephroGenex
Aug 14, 2015
Buy
Reiterated
2Ratings
0.00%
Fortress Biotech
Apr 28, 2016
Buy
Reiterated
4Ratings
0.00%
List of latest recommendations made by Vernon Bernardino. Click to expand and see Vernon Bernardino's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >